Clinical Trials Browser

Phase 1 × Interventional × DTRMWXHS-12 × Clear all

NCT03836768 2023-02-15

BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

Phase 1 Completed

Lymphoma, Mantle-Cell

NCT02900716 2020-11-27

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT02891590 2020-04-14

Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell